Oral & Topical Anaesthetics Market
Oral & Topical Anaesthetics Market Study by Non-Aqueous and Aqueous through Gels, Ointments, Solutions, and Adhesive Patch Administration From 2024 to 2034
Analysis of Oral & Topical Anaesthetics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT2279MR
- 16 Jan 2025
- Healthcare
- 170 Pages
- 40 Tables
- 40 Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Drug Class Type
- 6.2. Route Of Administration
- 6.3. Duration Of Action
- 6.4. Distribution Channel
- 7. Global Market Analysis and Forecast, By Drug Class Type
- 7.1. Non-aqueous
- 7.2. Aqueous
- 8. Global Market Analysis and Forecast, By Route Of Administration
- 8.1. Gels
- 8.2. Ointments
- 8.3. Solutions
- 8.4. Adhesive Patch
- 9. Global Market Analysis and Forecast, By Duration Of Action
- 9.1. Short
- 9.2. Medium
- 9.3. Long
- 10. Global Market Analysis and Forecast, By Distribution Channel
- 10.1. Hospitals
- 10.2. Dental Clinics
- 10.3. Pharmacies and Drug Stores
- 10.4. E-commerce
- 11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. Asia Pacific
- 11.6. East Asia
- 11.7. MEA
- 12. North America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 19. Sales Forecast by Drug Class Type, Route Of Administration, Duration Of Action, and Distribution Channel for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Astra Zeneca (UK)
- 21.2. Septodont (US)
- 21.3. Dentsply (US)
- 21.4. Sirona (US)
- 21.5. GlaxoSmithKline PLC (US)
- 21.6. Gilead Sciences Inc. (US)
- 21.7. Johnson & Johnson (US)
- 21.8. F. Hoffmann-La Roche Ltd. (Switzerland)
- 21.9. Baxter International Inc. (US)
- 21.10. Abbott Laboratories (US)
- 21.11. Hospira, Inc. (US)
- 21.12. Hikma Pharmaceuticals PLC (UK)
- 21.13. AbbVie Inc. (US)
- 21.14. Fresenius Se & Co. Kgaa (Germany)
- 21.15. Others
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Drug Class Type
Table 3: Global Market US$ Mn Forecast by Route Of Administration
Table 4: Global Market US$ Mn Forecast by Duration Of Action
Table 5: Global Market US$ Mn Forecast by Distribution Channel
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Drug Class Type
Table 8: North America Market US$ Mn Forecast by Route Of Administration
Table 9: North America Market US$ Mn Forecast by Duration Of Action
Table 10: North America Market US$ Mn Forecast by Distribution Channel
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Drug Class Type
Table 13: Latin America Market US$ Mn Forecast by Route Of Administration
Table 14: Latin America Market US$ Mn Forecast by Duration Of Action
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Drug Class Type
Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 19: Western Europe Market US$ Mn Forecast by Duration Of Action
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Drug Class Type
Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 24: Eastern Europe Market US$ Mn Forecast by Duration Of Action
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 26: Asia Pacific Market US$ Mn Forecast by Country
Table 27: Asia Pacific Market US$ Mn Forecast by Drug Class Type
Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration
Table 29: Asia Pacific Market US$ Mn Forecast by Duration Of Action
Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channel
Table 31: East Asia Market US$ Mn Forecast by Country
Table 32: East Asia Market US$ Mn Forecast by Drug Class Type
Table 33: East Asia Market US$ Mn Forecast by Route Of Administration
Table 34: East Asia Market US$ Mn Forecast by Duration Of Action
Table 35: East Asia Market US$ Mn Forecast by Distribution Channel
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Drug Class Type
Table 38: MEA Market US$ Mn Forecast by Route Of Administration
Table 39: MEA Market US$ Mn Forecast by Duration Of Action
Table 40: MEA Market US$ Mn Forecast by Distribution Channel
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Oral & Topical Anaesthetics Market